Mirae Asset Global Investments Co., Ltd. Enanta Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 706 shares of ENTA stock, worth $3,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
706Holding current value
$3,614% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.2MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$10.8 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$9.46 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$7.67 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$5.65 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $106M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...